<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03705728</url>
  </required_header>
  <id_info>
    <org_study_id>AG-DPO</org_study_id>
    <nct_id>NCT03705728</nct_id>
  </id_info>
  <brief_title>Automated Administration of Intravenous Compared With Inhalatory Anesthesia on the Occurrence of Postoperative Delirium</brief_title>
  <acronym>AG-DPO</acronym>
  <official_title>Impact of the Automated Administration of Intravenous Anesthesia Compared to Inhalatory Anesthesia on the Speed of Emergence and the Occurrence of Postoperative Delirium</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Clinical, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Clinical, France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The intravenous administration of anesthetic agents by a controller automatically-guided by
      an index of cerebral activity (i.e. the bispectral index) decreases the incidence of
      postoperative delirium, compared with an inhalational anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Scientific background Postoperative delirium (POD) is a common complication occurring in 5 to
      50 % of elderly patients following an operation. Delirium is a serious complication leading
      to many medical as well as social and economical consequences. Several studies suggest that,
      both, the choice of anesthetic agents and the conduction of anesthesia might decrease the
      incidence of POD.

      Objectives Study goal and primary aim: the intravenous administration of anesthetic agents by
      a controller automatically-guided by an index of cerebral activity (i.e. the bispectral
      index) decreases the incidence of POD, compared with an inhalational anesthesia.

      The primary aim of the present study (i.e. incidence of POD) will be assessed by the Nursing
      Delirium Screening Scale (NDSS).

      Secondary aims:

      Secondary aim 1: Assessment of a potential difference on the incidence of PONV between the 2
      groups of patients (i.e. intravenous vs. inhaled) by comparison of the number of episodes of
      nausea and vomiting and the need to treat this complications, between both groups.

      Secondary aim 2: study if the difference of in the impairment of cognitive function might be
      correlated either with the type of drugs used to conduct anesthesia or with the control the
      index of cerebral activity (i.e. the BIS). The respective influences of the control of the
      index of cerebral activity (i.e. the BIS) and of the anesthetic drugs on the occurrence of
      postoperative cognitive dysfunctions (POCD) will be assessed by comparing cognitive function
      tests on matched groups on the percentage of time spent in different ranges of values of the
      cortical index Population of patients Patients of 60 years old or more, having given their
      written informed consent and who should undergo a surgical procedure of at least one hour.

      Inclusion criterion

      Patients will be included in the study if:

        -  They are 60 years old or older,

        -  They have given their written informed consent,

        -  They have to undergo a surgical procedure of one hour or longer. Non-inclusion criterion

      Following patients will non be eligible for the current study:

        -  Pregnant women,

        -  Patients presenting a contra-indication to the monitoring of cerebral activity (i.e.
           intracranial surgery, neuroleptic or anti epileptic medications, pace maker),

        -  Patients presenting any allergy to propofol and or remifentanil,

        -  Patients under guardianship. Experimental protocol Information and inclusion of patients
           during the preoperative anesthetic assessment consultation First assessment of the NDSS
           at patient arrival in the operating room Randomization prior to the induction on the
           anesthesia Second NDSS just before patient leaving of PACU Recording of all PONV event
           as well as any administration of anti emetic drug

      Number of subjects: 1000 Number of center: 4 Duration of the research: 36 months

      Statistical Analysis: Sequential group analysis. The preoperative and postoperative NDSS test
      will be analyzed with an ANOVA for repeated-measure and multiple-comparison.

      The main criterion will be analyzed with a Kaplan-Meier survival analysis on the global data
      and with a Cox regression that will take into account the qualitative factors represented by
      the type of anesthesia

      Description of the Nursing Delirium Screening Scale (NDSS) that is a validated scale to
      assess POD at the bedside.

      Five areas are assessed: disorientation, inappropriate behavior, inappropriate communication,
      illusions or hallucinations, and psychomotor retardation Description A screening tool
      designed for nurses to use at the end of their shift to identify patients with delirium,
      derived from the Confusion Rating Scale (CRS). Raters reference behaviors that they have
      witnessed in the patient or that the patient'snurse has witnessed during their shift to score
      the NDSS.

      The NDSS can be rated one or more times daily.

      Scoring information Each feature is scored on 0-2 based on severity, with 0=absent, 1=mild,
      and 2=severe.

      Positive NDSS is score ≥ 2, maximum total score is 10.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 30, 2018</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>prospective randomized</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of the Nurse Delirium Screening Scale in the early postoperative period between intravenous vs halogenated general anesthesia</measure>
    <time_frame>Measure of the Nurse Delirium Screening Scale, up to an estimated maximum of 3 hours postoperatively</time_frame>
    <description>occurrence of POD as measured by the Nursing Delirium Screening Scale
The Nursing Delirium Scale
Symptom Symptom rating Disorientation 0 points 1 point 2 points Inappropriate behavior 0 points 1 point 2 points Inappropriate communication 0 points 1 point 2 points Illusion/hallucination 0 points 1 point 2 points Psychomotot retardation 0 points 1 point 2 points
Total score ≤ 2 points &gt; 2 points Delirium No Yes</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Postoperative Delirium</condition>
  <condition>Elderly Patient</condition>
  <condition>General Anesthetic Drug Adverse Reaction</condition>
  <arm_group>
    <arm_group_label>Intravenous group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Propofol &amp; remifentanil administration using the closed-loop controller with the &quot;Easy-TIVA&quot; platfrom.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>volatile anesthesia group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sevoflurane will be administered manually according to the BIS values. Remifentanil will be administered manually using a Target Controlled Infusion pump using the Minto model.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Propofol will be automatically administered according to the &quot;EasyTIVA&quot; device algorythm to maintain the BIS value within the 40-60 interval</description>
    <arm_group_label>Intravenous group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Sevoflurane will be manually administered to maintain the BIS value within the 40-60 interval</description>
    <arm_group_label>volatile anesthesia group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil automatic</intervention_name>
    <description>Remifentanil will be automatically administered according to the &quot;EasyTIVA&quot; device algorythm to maintain the BIS value within the 40-60 interval</description>
    <arm_group_label>Intravenous group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil manual</intervention_name>
    <description>Remifentanil will be manually administered to maintain the BIS value within the 40-60 interval</description>
    <arm_group_label>volatile anesthesia group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 59 year

          -  Informed written consent before enrolment;

          -  Procedure duration &gt; 60 min.

          -  Speaking French

          -  Possible contact one-month following surgery

        Exclusion Criteria:

          -  Contraindication of brain monitoring (intracranial surgery), pace-maker.

          -  Propofol or remifentanil allergy.

          -  Patients under guardianship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xavier Paqueron, MD PhD</last_name>
    <phone>+33545979562</phone>
    <email>xavier.paqueron@orange.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thierry Chazot, MD</last_name>
    <phone>+33629820241</phone>
    <email>tchazot@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Clinical</name>
      <address>
        <city>Soyaux</city>
        <state>Charente</state>
        <zip>16800</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier Paqueron, MD PhD</last_name>
      <phone>+33545979562</phone>
    </contact>
    <contact_backup>
      <last_name>Thierry Chazot, MD</last_name>
      <phone>+33629820241</phone>
      <email>tchazot@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>American Geriatrics Society Expert Panel on Postoperative Delirium in Older Adults. Postoperative delirium in older adults: best practice statement from the American Geriatrics Society. J Am Coll Surg. 2015 Feb;220(2):136-48.e1. doi: 10.1016/j.jamcollsurg.2014.10.019. Epub 2014 Nov 14.</citation>
    <PMID>25535170</PMID>
  </reference>
  <reference>
    <citation>Robinson TN, Raeburn CD, Tran ZV, Angles EM, Brenner LA, Moss M. Postoperative delirium in the elderly: risk factors and outcomes. Ann Surg. 2009 Jan;249(1):173-8. doi: 10.1097/SLA.0b013e31818e4776.</citation>
    <PMID>19106695</PMID>
  </reference>
  <reference>
    <citation>Saczynski JS, Marcantonio ER, Quach L, Fong TG, Gross A, Inouye SK, Jones RN. Cognitive trajectories after postoperative delirium. N Engl J Med. 2012 Jul 5;367(1):30-9. doi: 10.1056/NEJMoa1112923.</citation>
    <PMID>22762316</PMID>
  </reference>
  <reference>
    <citation>Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE Jr, Inouye SK, Bernard GR, Dittus RS. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004 Apr 14;291(14):1753-62.</citation>
    <PMID>15082703</PMID>
  </reference>
  <reference>
    <citation>Chan MT, Cheng BC, Lee TM, Gin T; CODA Trial Group. BIS-guided anesthesia decreases postoperative delirium and cognitive decline. J Neurosurg Anesthesiol. 2013 Jan;25(1):33-42. doi: 10.1097/ANA.0b013e3182712fba.</citation>
    <PMID>23027226</PMID>
  </reference>
  <reference>
    <citation>Radtke FM, Franck M, Lendner J, Krüger S, Wernecke KD, Spies CD. Monitoring depth of anaesthesia in a randomized trial decreases the rate of postoperative delirium but not postoperative cognitive dysfunction. Br J Anaesth. 2013 Jun;110 Suppl 1:i98-105. doi: 10.1093/bja/aet055. Epub 2013 Mar 28.</citation>
    <PMID>23539235</PMID>
  </reference>
  <reference>
    <citation>Fritz BA, Kalarickal PL, Maybrier HR, Muench MR, Dearth D, Chen Y, Escallier KE, Ben Abdallah A, Lin N, Avidan MS. Intraoperative Electroencephalogram Suppression Predicts Postoperative Delirium. Anesth Analg. 2016 Jan;122(1):234-42. doi: 10.1213/ANE.0000000000000989.</citation>
    <PMID>26418126</PMID>
  </reference>
  <reference>
    <citation>Liu N, Chazot T, Hamada S, Landais A, Boichut N, Dussaussoy C, Trillat B, Beydon L, Samain E, Sessler DI, Fischler M. Closed-loop coadministration of propofol and remifentanil guided by bispectral index: a randomized multicenter study. Anesth Analg. 2011 Mar;112(3):546-57. doi: 10.1213/ANE.0b013e318205680b. Epub 2011 Jan 13.</citation>
    <PMID>21233500</PMID>
  </reference>
  <reference>
    <citation>Besch G, Liu N, Samain E, Pericard C, Boichut N, Mercier M, Chazot T, Pili-Floury S. Occurrence of and risk factors for electroencephalogram burst suppression during propofol-remifentanil anaesthesia. Br J Anaesth. 2011 Nov;107(5):749-56. doi: 10.1093/bja/aer235. Epub 2011 Aug 8.</citation>
    <PMID>21828343</PMID>
  </reference>
  <reference>
    <citation>Liu N, Lory C, Assenzo V, Cocard V, Chazot T, Le Guen M, Sessler DI, Journois D, Fischler M. Feasibility of closed-loop co-administration of propofol and remifentanil guided by the bispectral index in obese patients: a prospective cohort comparison. Br J Anaesth. 2015 Apr;114(4):605-14. doi: 10.1093/bja/aeu401. Epub 2014 Dec 10.</citation>
    <PMID>25500680</PMID>
  </reference>
  <reference>
    <citation>Orliaguet GA, Benabbes Lambert F, Chazot T, Glasman P, Fischler M, Liu N. Feasibility of closed-loop titration of propofol and remifentanil guided by the bispectral monitor in pediatric and adolescent patients: a prospective randomized study. Anesthesiology. 2015 Apr;122(4):759-67. doi: 10.1097/ALN.0000000000000577.</citation>
    <PMID>25545655</PMID>
  </reference>
  <reference>
    <citation>Liu N, Chazot T, Trillat B, Michel-Cherqui M, Marandon JY, Law-Koune JD, Rives B, Fischler M; Foch Lung Transplant Group. Closed-loop control of consciousness during lung transplantation: an observational study. J Cardiothorac Vasc Anesth. 2008 Aug;22(4):611-5. doi: 10.1053/j.jvca.2008.04.022. Epub 2008 Jun 25.</citation>
    <PMID>18662642</PMID>
  </reference>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 2, 2018</study_first_submitted>
  <study_first_submitted_qc>October 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 15, 2018</study_first_posted>
  <last_update_submitted>October 16, 2018</last_update_submitted>
  <last_update_submitted_qc>October 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>anesthesia, general</keyword>
  <keyword>postoperative delirium</keyword>
  <keyword>postoperative nausea and vomiting</keyword>
  <keyword>elderly</keyword>
  <keyword>total intravenous anesthesia</keyword>
  <keyword>closed-loop anesthesia</keyword>
  <keyword>EEG monitoring</keyword>
  <keyword>propofol</keyword>
  <keyword>remifentanil</keyword>
  <keyword>sevoflurane</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Drug-Related Side Effects and Adverse Reactions</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

